Alfeson Sustained Release Tablets (Eperisone Hydrochloride)

Adult dose

As this medication is a sustained release tablet, it should be taken whole without crushing, splitting, or chewing. Adults: 1 tablet (75 mg of eperisone hydrochloride) taken orally twice daily after meals. Adjustment may be made based on age and symptoms.

This medication should not be used in patients with hypersensitivity or severe myasthenia gravis. It should be used cautiously in patients with a history of hypersensitivity to the drug or impaired liver function, as liver function may deteriorate. When using this medication, there is a rare possibility of serious allergic reactions such as shock or anaphylaxis, so if symptoms such as redness, itching, hives, swelling, or shortness of breath occur, use should be discontinued immediately and medical attention sought. Also, serious skin conditions such as toxic epidermal necrolysis or Stevens-Johnson syndrome may occur, so if symptoms such as fever, erythema, blisters, itching, conjunctival injection, or stomatitis appear, the medication should be discontinued immediately and medical advice should be sought. Side effects such as abnormal liver function, renal dysfunction, anemia, rash, insomnia, drowsiness, headache, dyspepsia, nausea, vomiting, constipation, diarrhea, abdominal pain, urinary retention, weakness, dizziness, and muscle stiffness may occasionally occur, so if any unusual symptoms arise, consult a doctor. During treatment with this drug, drowsiness or decreased concentration may occur, so it is advisable to avoid driving or operating hazardous machinery. For women who are pregnant or may become pregnant, the safety of this medication has not been established, and it should only be used when the benefits of treatment are deemed greater than the risks, and during breastfeeding, it should be avoided if possible or breastfeeding should be discontinued if absolutely necessary. Safety in children has not been sufficiently confirmed, so it should be administered cautiously to children. In elderly patients, caution is needed due to possible decline in physical function, including dose reduction.

Serious side effects

• Hives
• severe swelling
• edema
• shortness of breath
• shock
• anaphylaxis
• toxic epidermal necrolysis
• Lyell's syndrome
• mucocutaneous syndrome
• Stevens-Johnson syndrome

Mild side effects

• Nausea
• vomiting
• loss of appetite
• gastrointestinal discomfort
• thirst
• constipation
• diarrhea
• abdominal pain
• abdominal fullness
• stomatitis

This medication should be stored in a tightly closed container to prevent exposure to air and moisture. It is best to maintain room temperature between 1 degree and 30 degrees Celsius. This helps to preserve the effectiveness of the medication and prevent degradation.

Appearance

White to almost white round sustained release film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle